Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MINODRONIC ACID for Osteoporosis postmenopausal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where MINODRONIC ACID was used for Osteoporosis postmenopausal.

Most Reported Side Effects for MINODRONIC ACID

Side Effect Reports % Deaths Hosp.
Osteonecrosis of jaw 26 18.7% 0 10
Atypical femur fracture 21 15.1% 0 11
Fall 10 7.2% 1 7
Osteomyelitis 8 5.8% 0 4
Nausea 7 5.0% 0 5
Decreased appetite 6 4.3% 0 5
Dizziness 6 4.3% 0 6
Erythema 6 4.3% 0 2
Off label use 6 4.3% 0 3
Spinal fracture 6 4.3% 0 0
Bone disorder 5 3.6% 0 1
Femur fracture 5 3.6% 0 4
Pyrexia 5 3.6% 1 4

Other Indications for MINODRONIC ACID

Osteoporosis (65) Product used for unknown indication (32) Osteoporosis prophylaxis (5)

Other Drugs Used for Osteoporosis postmenopausal

DENOSUMAB (18,350) ABALOPARATIDE (7,932) PROLIA (1,775) ROMOSOZUMAB-AQQG (1,401) TERIPARATIDE (263) ALENDRONATE (262) ZOLEDRONIC ACID (225) ALENDRONATE\CHOLECALCIFEROL (135) IBANDRONIC ACID (116) ALENDRONIC ACID (105)

Related Pages

MINODRONIC ACID Full Profile All Osteoporosis postmenopausal Drugs MINODRONIC ACID Demographics MINODRONIC ACID Timeline